BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 31199797)

  • 1. DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequences.
    Lee I; Keum J; Nam H
    PLoS Comput Biol; 2019 Jun; 15(6):e1007129. PubMed ID: 31199797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Drug-Target Interactions with Deep-Embedding Learning of Graphs and Sequences.
    Chen W; Chen G; Zhao L; Chen CY
    J Phys Chem A; 2021 Jul; 125(25):5633-5642. PubMed ID: 34142824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSConv2d: A 2-D Structural Convolution Neural Network with a Channel and Spatial Attention Mechanism for Protein-Ligand Binding Affinity Prediction.
    Wang X; Liu D; Zhu J; Rodriguez-Paton A; Song T
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33925310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence-based prediction of protein binding regions and drug-target interactions.
    Lee I; Nam H
    J Cheminform; 2022 Feb; 14(1):5. PubMed ID: 35135622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DTI-CDF: a cascade deep forest model towards the prediction of drug-target interactions based on hybrid features.
    Chu Y; Kaushik AC; Wang X; Wang W; Zhang Y; Shan X; Salahub DR; Xiong Y; Wei DQ
    Brief Bioinform; 2021 Jan; 22(1):451-462. PubMed ID: 31885041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Learning in Drug Target Interaction Prediction: Current and Future Perspectives.
    Abbasi K; Razzaghi P; Poso A; Ghanbari-Ara S; Masoudi-Nejad A
    Curr Med Chem; 2021; 28(11):2100-2113. PubMed ID: 32895036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Machine Learning Approach for Drug-target Interaction Prediction using Wrapper Feature Selection and Class Balancing.
    Redkar S; Mondal S; Joseph A; Hareesha KS
    Mol Inform; 2020 May; 39(5):e1900062. PubMed ID: 32003548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Drug-Target Interactions Based on Small Positive Samples.
    Hu P; Chan KCC; Hu Y
    Curr Protein Pept Sci; 2018; 19(5):479-487. PubMed ID: 27829343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting drug-target interactions using restricted Boltzmann machines.
    Wang Y; Zeng J
    Bioinformatics; 2013 Jul; 29(13):i126-34. PubMed ID: 23812976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AttentionDTA: Drug-Target Binding Affinity Prediction by Sequence-Based Deep Learning With Attention Mechanism.
    Zhao Q; Duan G; Yang M; Cheng Z; Li Y; Wang J
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(2):852-863. PubMed ID: 35471889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HyperAttentionDTI: improving drug-protein interaction prediction by sequence-based deep learning with attention mechanism.
    Zhao Q; Zhao H; Zheng K; Wang J
    Bioinformatics; 2022 Jan; 38(3):655-662. PubMed ID: 34664614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An end-to-end heterogeneous graph representation learning-based framework for drug-target interaction prediction.
    Peng J; Wang Y; Guan J; Li J; Han R; Hao J; Wei Z; Shang X
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33517357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting protein-ligand binding residues with deep convolutional neural networks.
    Cui Y; Dong Q; Hong D; Wang X
    BMC Bioinformatics; 2019 Feb; 20(1):93. PubMed ID: 30808287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICAN: Interpretable cross-attention network for identifying drug and target protein interactions.
    Kurata H; Tsukiyama S
    PLoS One; 2022; 17(10):e0276609. PubMed ID: 36279284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DTI-MLCD: predicting drug-target interactions using multi-label learning with community detection method.
    Chu Y; Shan X; Chen T; Jiang M; Wang Y; Wang Q; Salahub DR; Xiong Y; Wei DQ
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32964234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CoaDTI: multi-modal co-attention based framework for drug-target interaction annotation.
    Huang L; Lin J; Liu R; Zheng Z; Meng L; Chen X; Li X; Wong KC
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36274236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DeepFusionDTA: Drug-Target Binding Affinity Prediction With Information Fusion and Hybrid Deep-Learning Ensemble Model.
    Pu Y; Li J; Tang J; Guo F
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(5):2760-2769. PubMed ID: 34379594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep-Learning-Based Drug-Target Interaction Prediction.
    Wen M; Zhang Z; Niu S; Sha H; Yang R; Yun Y; Lu H
    J Proteome Res; 2017 Apr; 16(4):1401-1409. PubMed ID: 28264154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A learning-based method for drug-target interaction prediction based on feature representation learning and deep neural network.
    Peng J; Li J; Shang X
    BMC Bioinformatics; 2020 Sep; 21(Suppl 13):394. PubMed ID: 32938374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.